MedPath

Tricida, Inc.

Tricida, Inc. logo
🇺🇸United States
Ownership
Public
Established
2013-01-01
Employees
57
Market Cap
-
Website
http://www.tricida.com

Clinical Trials

13

Active:9
Completed:3

Trial Phases

2 Phases

Phase 1:10
Phase 3:3

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (13 trials with phase data)• Click on a phase to view related trials

Phase 1
10 (76.9%)
Phase 3
3 (23.1%)

Evaluation of Effect of TRC101 on Progression of Chronic Kidney Disease in Subjects With Metabolic Acidosis

Phase 3
Terminated
Conditions
Chronic Kidney Disease
Metabolic Acidosis
Interventions
Drug: Placebo
First Posted Date
2018-10-18
Last Posted Date
2022-10-14
Lead Sponsor
Tricida, Inc.
Target Recruit Count
1480
Registration Number
NCT03710291
Locations
🇺🇸

Investigative Site 4136, Azusa, California, United States

🇺🇸

Investigative Site 4148, Denver, Colorado, United States

🇺🇸

Investigative Site 4157, Boca Raton, Florida, United States

and more 200 locations

Long-term Safety Extension to Study TRCA-301

Phase 3
Completed
Conditions
Metabolic Acidosis
Interventions
Drug: Placebo
First Posted Date
2018-01-04
Last Posted Date
2021-10-22
Lead Sponsor
Tricida, Inc.
Target Recruit Count
196
Registration Number
NCT03390842
Locations
🇺🇸

Investigative Site 55, Phoenix, Arizona, United States

🇺🇸

Investigative Site 91, Los Angeles, California, United States

🇺🇸

Investigative Site 59, Hialeah, Florida, United States

and more 26 locations

Evaluation of TRC101 in Subjects With Metabolic Acidosis Associated With Chronic Kidney Disease

Phase 3
Completed
Conditions
Metabolic Acidosis
Interventions
Drug: Placebo
First Posted Date
2017-10-23
Last Posted Date
2021-04-26
Lead Sponsor
Tricida, Inc.
Target Recruit Count
217
Registration Number
NCT03317444
Locations
🇺🇸

Investigative Site 55, Phoenix, Arizona, United States

🇺🇸

Investigative Site 56, Chula Vista, California, United States

🇺🇸

Investigative Site 91, Los Angeles, California, United States

and more 41 locations

Evaluation of TRC101 in Subjects With Chronic Kidney Disease and Metabolic Acidosis

Phase 1
Completed
Conditions
Acidosis
Interventions
Drug: Placebo
First Posted Date
2016-06-22
Last Posted Date
2020-01-14
Lead Sponsor
Tricida, Inc.
Target Recruit Count
135
Registration Number
NCT02809183
Locations
🇧🇬

Investigative Site 1, Sofia, Bulgaria

🇬🇪

Investigative Site 3, Tbilisi, Georgia

🇬🇪

Investigative Site 4, Tbilisi, Georgia

and more 2 locations

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.